Food News and Research

RSS

Nilotinib and Dasatinib show promise as therapy for chronic myelogenous leukemia

Two drugs approved for use as second line therapy for chronic myelogenous leukemia are showing promising results as frontline therapy for newly diagnosed patients in two clinical trials, research teams led by scientists at The University of Texas M. D. Anderson Cancer Center report at the 49th annual meeting of the American Society of Hematology.

10 Dec 2007

Plenty of turkey for Brits this Christmas despite bird flu

Brits will still be alright for their Christmas turkey this year despite the bird flu outbreaks.

10 Dec 2007

Diabetic jailed for dangerous driving

A British man has been jailed for causing death by dangerous driving because he experienced a diabetic blackout while behind the wheel of his car.

9 Dec 2007

Human to human spread of bird flu suspected in China

Health authorities in China have announced that the father of a man who died from the H5N1 strain of bird flu last week also has the lethal virus.

9 Dec 2007

Most baby-food manufacturers using toxic chemical in packaging

An environmental organization in the U.S. says that cans containing liquid infant formula and sold in North America, contain the toxic chemical Bisphenol A (BPA).

6 Dec 2007

Health inspectors took bribes for food health certificates

At a time when consumers confidence has been repeatedly shaken by an almost continual series of food scares often involving contaminated food, two former Chicago Public Health Department inspectors are facing charges by federal authorities in the United States for allegedly taking bribes for food-service sanitation certificates.

6 Dec 2007

Botox shows potential for bladder spasms and leakages

Eight years ago, Lynette Kunz suffered a severe spinal cord injury that left her a quadriplegic and sufferer of involuntary bladder contractions.

5 Dec 2007

Smell experience during critical period alters brain

Unlike the circuitry of the visual system, that of the olfactory system was thought to be hardwired: Once the neurons had formed, no amount of sensory input could change their arrangement.

5 Dec 2007

Costs of lower-calorie foods are rising the fastest

As food prices rise, the costs of lower-calorie foods are rising the fastest, according to a University of Washington study appearing in the December issue of the Journal of the American Dietetic Association.

5 Dec 2007

Myocor receives trial approval for percutaneously implanted iCoapsys system

Myocor, Inc. announced that the U.S. Food and Drug Administration has granted conditional approval of the Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) feasibility study.

5 Dec 2007

Close families raise more independent adults

You're already 25 and you still live with your parents. You're 26 and you still bring your laundry take home food from your mother.

5 Dec 2007

Caraco Pharmaceutical Labs announces FDA approval to market generic Norvasc

Caraco Pharmaceutical Laboratories has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg, 5 mg, and 10 mg (Amlodipine).

5 Dec 2007

Honey a cheaper and more effective treatment for children's coughs than cough medicine

Experts in the United States say when it comes to children's coughs, natural honey offers a cheaper and more effective alternative to expensive over-the-counter cough medicines.

5 Dec 2007

The latest food scare and it's not from China!

According to health officials in the U.S. a candy imported from Mexico has been found to contain high levels of lead.

5 Dec 2007

Peanut allergies soar and appear much earlier

Scientists in the U.S. have voiced their concern that peanut allergies are appearing much earlier in children.

4 Dec 2007

Chips and crisps on a daily basis raise a woman's cancer risk

Dutch scientists say by eating crisps or chips on a daily basis a woman could be doubling her risk of ovarian or womb cancer.

4 Dec 2007

Re-engineered Gleevec reduces heart risks

Using a new bottom-up approach for rational drug design, researchers at Rice University and the University of Texas M. D. Anderson Cancer Center have reengineered the powerful anticancer drug imatinib - best known by its brand name Gleevec - to more specifically target one type of cancer while potentially curbing a rare life-threatening cardiotoxic side effect.

4 Dec 2007